Generic drug enforcement: hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment
U.S. Government Printing Office, 1991 - Political Science - 99 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Abbott Laboratories abbreviated drug application Agency Agency's amendment Barr Laboratories Barr's ANDAs bioequivalence Bliley Calcium Channel Blocker chemistry reviewer civil penalty Cohen Committee conjugated estrogens convicted criminal debarment legislation debarment period debarred under subsection decision deficiency letter Drug Administration drug approval process drug companies drug division effect employee Energy and Commerce enforcement Enprostil Erythromycin Estolate Federal Federal Food felony firms Food and Drug Forscey fraud policy GPIA guilty hearing Hoechst Human Services illegal Inspector issues June June 17 Kibbe Last year's bill mandatory debarment manufacturing ment minimum debarment Mylan Mylan Laboratories NDA holders off-label offense Office Oversight and Investigations paragraph pending period of debarment permissive debarment person Pfizer Pharmaceutical Pink Sheet prepared statement procedures regulated Retin-A retroactive sanction scientific Secretary finds Secretary's special early termination submission submitted subparagraph suspension Syntex testimony Thank tion violation Waxman withdraw approval wrongdoing